Unraveling the antifungal activity of a South American rattlesnake toxin crotamine

Detalhes bibliográficos
Autor(a) principal: Yamane, Érica Sayuri [UNIFESP]
Data de Publicação: 2013
Outros Autores: Bizerra, Fernando César [UNIFESP], Oliveira, Eduardo B., Moreira, Jéssica Tanaka [UNIFESP], Rajabi, Mohsen, Nunes, Gabriel Luiz Cocco [UNIFESP], Souza, Ana O. de, Silva, Ismael Dale Cotrim Guerreiro da [UNIFESP], Yamane, Tetsuo, Karpel, Richard L., Silva, Pedro I., Hayashi, Mirian Akemi Furuie [UNIFESP]
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNIFESP
Texto Completo: http://dx.doi.org/10.1016/j.biochi.2012.09.019
http://repositorio.unifesp.br/handle/11600/35889
Resumo: Crotamine is a highly basic peptide from the venom of Crotalus durissus terrificus rattlesnake. Its common gene ancestry and structural similarity with the beta-defensins, mainly due to an identical disulfide bond pattern, stimulated us to assess the antimicrobial properties of native, recombinant, and chemically synthesized crotamine. Antimicrobial activities against standard strains and clinical isolates were analyzed by the colorimetric microdilution method showing a weak antibacterial activity against both Gram-positive and Gram-negative bacteria [MIC (Minimum Inhibitory Concentration) of 50->200 mu g/mL], with the exception of Micrococcus luteus [MIC ranging from 1 to 2 mu g/mL]. No detectable activity was observed for the filamentous fungus Aspergillus fumigatus and Trichophyton rubrum at concentrations up to 125 mu g/mL. However, a pronounced antifungal activity against Candida spp., Trichosporon spp., and Cryptococcus neoformans [12.5-50.0 mu g/mL] was observed. Chemically produced synthetic crotamine in general displayed MIC values similar to those observed for native crotamine, whereas recombinant crotamine was overridingly more potent in most assays. On the other hand, derived short linear peptides were not very effective apart from a few exceptions. Pronounced ultrastructure alteration in Candida albicans elicited by crotamine was observed by electron microscopy analyses. the peculiar specificity for highly proliferating cells was confirmed here showing potential low cytotoxic effect of crotamine against nontumoral mammal cell lines (HEK293, PC12, and primary culture astrocyte cells) compared to tumoral B16F10 cells, and no hemolytic activity was observed. Taken together these results suggest that, at low concentration, crotamine is a potentially valuable anti-yeast or candicidal agent, with low harmful effects on normal mammal cells, justifying further studies on its mechanisms of action aiming medical and industrial applications. (C) 2012 Elsevier Masson SAS. All rights reserved.
id UFSP_e105371daa31f4f62af5e70ca4f175b4
oai_identifier_str oai:repositorio.unifesp.br/:11600/35889
network_acronym_str UFSP
network_name_str Repositório Institucional da UNIFESP
repository_id_str 3465
spelling Unraveling the antifungal activity of a South American rattlesnake toxin crotamineRattlesnake toxinAntimicrobial activityAmphipathic peptideClinical strainCrotamine is a highly basic peptide from the venom of Crotalus durissus terrificus rattlesnake. Its common gene ancestry and structural similarity with the beta-defensins, mainly due to an identical disulfide bond pattern, stimulated us to assess the antimicrobial properties of native, recombinant, and chemically synthesized crotamine. Antimicrobial activities against standard strains and clinical isolates were analyzed by the colorimetric microdilution method showing a weak antibacterial activity against both Gram-positive and Gram-negative bacteria [MIC (Minimum Inhibitory Concentration) of 50->200 mu g/mL], with the exception of Micrococcus luteus [MIC ranging from 1 to 2 mu g/mL]. No detectable activity was observed for the filamentous fungus Aspergillus fumigatus and Trichophyton rubrum at concentrations up to 125 mu g/mL. However, a pronounced antifungal activity against Candida spp., Trichosporon spp., and Cryptococcus neoformans [12.5-50.0 mu g/mL] was observed. Chemically produced synthetic crotamine in general displayed MIC values similar to those observed for native crotamine, whereas recombinant crotamine was overridingly more potent in most assays. On the other hand, derived short linear peptides were not very effective apart from a few exceptions. Pronounced ultrastructure alteration in Candida albicans elicited by crotamine was observed by electron microscopy analyses. the peculiar specificity for highly proliferating cells was confirmed here showing potential low cytotoxic effect of crotamine against nontumoral mammal cell lines (HEK293, PC12, and primary culture astrocyte cells) compared to tumoral B16F10 cells, and no hemolytic activity was observed. Taken together these results suggest that, at low concentration, crotamine is a potentially valuable anti-yeast or candicidal agent, with low harmful effects on normal mammal cells, justifying further studies on its mechanisms of action aiming medical and industrial applications. (C) 2012 Elsevier Masson SAS. All rights reserved.Universidade Federal de São Paulo UNIFESP, Dept Farmacol, BR-04044020 São Paulo, BrazilUniversidade Federal de São Paulo UNIFESP, Dept Med, BR-04044020 São Paulo, BrazilUniv São Paulo, Dept Bioquim & Imunol, BR-14049 Ribeirao Preto, BrazilUniv Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USAUniv Maryland, Dept Biochem & Mol Biol, Baltimore, MD 21201 USAUniversidade Federal de São Paulo UNIFESP, Dept Bioquim, BR-04044020 São Paulo, BrazilInst Butantan, Lab Bioquim & Biofis, BR-05503900 São Paulo, BrazilUniversidade Federal de São Paulo UNIFESP, Dept Ginecol, BR-04044020 São Paulo, BrazilCBA, Lab Bioquim & Biol Mol, Manaus, Amazonas, BrazilUniv Maryland Baltimore Cty, Dept Chem & Biochem, Baltimore, MD 21250 USAInst Butantan, Ctr Toxinol Aplicada CAT CEPID, BR-05503900 São Paulo, BrazilUniversidade Federal de São Paulo UNIFESP, Dept Farmacol, BR-04044020 São Paulo, BrazilUniversidade Federal de São Paulo UNIFESP, Dept Med, BR-04044020 São Paulo, BrazilUniversidade Federal de São Paulo UNIFESP, Dept Bioquim, BR-04044020 São Paulo, BrazilUniversidade Federal de São Paulo UNIFESP, Dept Ginecol, BR-04044020 São Paulo, BrazilWeb of ScienceFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)University of Maryland Baltimore County Designated Research Initiative FundElsevier B.V.Universidade Federal de São Paulo (UNIFESP)Universidade de São Paulo (USP)Univ MarylandInst ButantanCBAUniv Maryland Baltimore CtyYamane, Érica Sayuri [UNIFESP]Bizerra, Fernando César [UNIFESP]Oliveira, Eduardo B.Moreira, Jéssica Tanaka [UNIFESP]Rajabi, MohsenNunes, Gabriel Luiz Cocco [UNIFESP]Souza, Ana O. deSilva, Ismael Dale Cotrim Guerreiro da [UNIFESP]Yamane, TetsuoKarpel, Richard L.Silva, Pedro I.Hayashi, Mirian Akemi Furuie [UNIFESP]2016-01-24T14:31:09Z2016-01-24T14:31:09Z2013-02-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion231-240application/pdfhttp://dx.doi.org/10.1016/j.biochi.2012.09.019Biochimie. Paris: Elsevier France-editions Scientifiques Medicales Elsevier, v. 95, n. 2, p. 231-240, 2013.10.1016/j.biochi.2012.09.019WOS000315614200012.pdf0300-9084http://repositorio.unifesp.br/handle/11600/35889WOS:000315614200012engBiochimieinfo:eu-repo/semantics/openAccesshttp://www.elsevier.com/about/open-access/open-access-policies/article-posting-policyreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2024-08-08T18:04:30Zoai:repositorio.unifesp.br/:11600/35889Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652024-08-08T18:04:30Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false
dc.title.none.fl_str_mv Unraveling the antifungal activity of a South American rattlesnake toxin crotamine
title Unraveling the antifungal activity of a South American rattlesnake toxin crotamine
spellingShingle Unraveling the antifungal activity of a South American rattlesnake toxin crotamine
Yamane, Érica Sayuri [UNIFESP]
Rattlesnake toxin
Antimicrobial activity
Amphipathic peptide
Clinical strain
title_short Unraveling the antifungal activity of a South American rattlesnake toxin crotamine
title_full Unraveling the antifungal activity of a South American rattlesnake toxin crotamine
title_fullStr Unraveling the antifungal activity of a South American rattlesnake toxin crotamine
title_full_unstemmed Unraveling the antifungal activity of a South American rattlesnake toxin crotamine
title_sort Unraveling the antifungal activity of a South American rattlesnake toxin crotamine
author Yamane, Érica Sayuri [UNIFESP]
author_facet Yamane, Érica Sayuri [UNIFESP]
Bizerra, Fernando César [UNIFESP]
Oliveira, Eduardo B.
Moreira, Jéssica Tanaka [UNIFESP]
Rajabi, Mohsen
Nunes, Gabriel Luiz Cocco [UNIFESP]
Souza, Ana O. de
Silva, Ismael Dale Cotrim Guerreiro da [UNIFESP]
Yamane, Tetsuo
Karpel, Richard L.
Silva, Pedro I.
Hayashi, Mirian Akemi Furuie [UNIFESP]
author_role author
author2 Bizerra, Fernando César [UNIFESP]
Oliveira, Eduardo B.
Moreira, Jéssica Tanaka [UNIFESP]
Rajabi, Mohsen
Nunes, Gabriel Luiz Cocco [UNIFESP]
Souza, Ana O. de
Silva, Ismael Dale Cotrim Guerreiro da [UNIFESP]
Yamane, Tetsuo
Karpel, Richard L.
Silva, Pedro I.
Hayashi, Mirian Akemi Furuie [UNIFESP]
author2_role author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Universidade Federal de São Paulo (UNIFESP)
Universidade de São Paulo (USP)
Univ Maryland
Inst Butantan
CBA
Univ Maryland Baltimore Cty
dc.contributor.author.fl_str_mv Yamane, Érica Sayuri [UNIFESP]
Bizerra, Fernando César [UNIFESP]
Oliveira, Eduardo B.
Moreira, Jéssica Tanaka [UNIFESP]
Rajabi, Mohsen
Nunes, Gabriel Luiz Cocco [UNIFESP]
Souza, Ana O. de
Silva, Ismael Dale Cotrim Guerreiro da [UNIFESP]
Yamane, Tetsuo
Karpel, Richard L.
Silva, Pedro I.
Hayashi, Mirian Akemi Furuie [UNIFESP]
dc.subject.por.fl_str_mv Rattlesnake toxin
Antimicrobial activity
Amphipathic peptide
Clinical strain
topic Rattlesnake toxin
Antimicrobial activity
Amphipathic peptide
Clinical strain
description Crotamine is a highly basic peptide from the venom of Crotalus durissus terrificus rattlesnake. Its common gene ancestry and structural similarity with the beta-defensins, mainly due to an identical disulfide bond pattern, stimulated us to assess the antimicrobial properties of native, recombinant, and chemically synthesized crotamine. Antimicrobial activities against standard strains and clinical isolates were analyzed by the colorimetric microdilution method showing a weak antibacterial activity against both Gram-positive and Gram-negative bacteria [MIC (Minimum Inhibitory Concentration) of 50->200 mu g/mL], with the exception of Micrococcus luteus [MIC ranging from 1 to 2 mu g/mL]. No detectable activity was observed for the filamentous fungus Aspergillus fumigatus and Trichophyton rubrum at concentrations up to 125 mu g/mL. However, a pronounced antifungal activity against Candida spp., Trichosporon spp., and Cryptococcus neoformans [12.5-50.0 mu g/mL] was observed. Chemically produced synthetic crotamine in general displayed MIC values similar to those observed for native crotamine, whereas recombinant crotamine was overridingly more potent in most assays. On the other hand, derived short linear peptides were not very effective apart from a few exceptions. Pronounced ultrastructure alteration in Candida albicans elicited by crotamine was observed by electron microscopy analyses. the peculiar specificity for highly proliferating cells was confirmed here showing potential low cytotoxic effect of crotamine against nontumoral mammal cell lines (HEK293, PC12, and primary culture astrocyte cells) compared to tumoral B16F10 cells, and no hemolytic activity was observed. Taken together these results suggest that, at low concentration, crotamine is a potentially valuable anti-yeast or candicidal agent, with low harmful effects on normal mammal cells, justifying further studies on its mechanisms of action aiming medical and industrial applications. (C) 2012 Elsevier Masson SAS. All rights reserved.
publishDate 2013
dc.date.none.fl_str_mv 2013-02-01
2016-01-24T14:31:09Z
2016-01-24T14:31:09Z
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.1016/j.biochi.2012.09.019
Biochimie. Paris: Elsevier France-editions Scientifiques Medicales Elsevier, v. 95, n. 2, p. 231-240, 2013.
10.1016/j.biochi.2012.09.019
WOS000315614200012.pdf
0300-9084
http://repositorio.unifesp.br/handle/11600/35889
WOS:000315614200012
url http://dx.doi.org/10.1016/j.biochi.2012.09.019
http://repositorio.unifesp.br/handle/11600/35889
identifier_str_mv Biochimie. Paris: Elsevier France-editions Scientifiques Medicales Elsevier, v. 95, n. 2, p. 231-240, 2013.
10.1016/j.biochi.2012.09.019
WOS000315614200012.pdf
0300-9084
WOS:000315614200012
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Biochimie
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
http://www.elsevier.com/about/open-access/open-access-policies/article-posting-policy
eu_rights_str_mv openAccess
rights_invalid_str_mv http://www.elsevier.com/about/open-access/open-access-policies/article-posting-policy
dc.format.none.fl_str_mv 231-240
application/pdf
dc.publisher.none.fl_str_mv Elsevier B.V.
publisher.none.fl_str_mv Elsevier B.V.
dc.source.none.fl_str_mv reponame:Repositório Institucional da UNIFESP
instname:Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
instname_str Universidade Federal de São Paulo (UNIFESP)
instacron_str UNIFESP
institution UNIFESP
reponame_str Repositório Institucional da UNIFESP
collection Repositório Institucional da UNIFESP
repository.name.fl_str_mv Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)
repository.mail.fl_str_mv biblioteca.csp@unifesp.br
_version_ 1814268429013614592